1 January 2023 false No description of principal activity Taxfiler 2024.5 09917579business:PrivateLimitedCompanyLtd2023-01-012023-12-31 099175792022-12-31 099175792023-01-012023-12-31 09917579business:AuditExempt-NoAccountantsReport2023-01-012023-12-31 09917579business:FilletedAccounts2023-01-012023-12-31 099175792023-12-31 09917579business:Director12023-01-012023-12-31 09917579business:Director22023-01-012023-12-31 09917579business:RegisteredOffice2023-01-012023-12-31 099175792022-12-31 09917579core:WithinOneYear2023-12-31 09917579core:WithinOneYear2022-12-31 09917579core:AfterOneYear2023-12-31 09917579core:AfterOneYear2022-12-31 09917579core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 09917579core:ShareCapitalcore:PreviouslyStatedAmount2022-12-31 09917579core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 09917579core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 09917579core:PreviouslyStatedAmount2023-12-31 09917579core:PreviouslyStatedAmount2022-12-31 09917579business:SmallEntities2023-01-012023-12-31 09917579countries:EnglandWales2023-01-012023-12-31 09917579core:PlantMachinery2023-01-012023-12-31 09917579core:MotorVehicles2023-01-012023-12-31 09917579core:FurnitureFittings2023-01-012023-12-31 09917579core:ComputerEquipment2023-01-012023-12-31 09917579core:OtherPropertyPlantEquipment2023-01-012023-12-31 09917579core:PlantMachinery2022-12-31 09917579core:PlantMachinery2023-12-31 099175792022-01-012022-12-31 iso4217:GBP xbrli:pure
Company Registration No. 09917579 (England and Wales)
Cardiac Health Diagnostics Limited Unaudited accounts for the year ended 31 December 2023
Cardiac Health Diagnostics Limited Unaudited accounts Contents
Page
- 2 -
Cardiac Health Diagnostics Limited Company Information for the year ended 31 December 2023
Directors
Richard Sacks Sharon Owen
Company Number
09917579 (England and Wales)
Registered Office
White House Cottage The Cathedral Green Cardiff South Glamorgan CF5 2EB Wales
Accountants
Capital Accountancy (South Wales) Ltd 9 Dunraven Street Aberkenfig Bridgend CF32 9AS
- 3 -
Cardiac Health Diagnostics Limited Statement of financial position as at 31 December 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
1,848 
3,170 
Creditors: amounts falling due within one year
(102)
- 
Net current liabilities
(102)
- 
Total assets less current liabilities
1,746 
3,170 
Creditors: amounts falling due after more than one year
(6,088)
(6,088)
Provisions for liabilities
Other provisions
(500)
(500)
Net liabilities
(4,842)
(3,418)
Capital and reserves
Called up share capital
(2)
- 
Profit and loss account
(4,840)
(3,418)
Shareholders' funds
(4,842)
(3,418)
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 19 September 2024 and were signed on its behalf by
Richard Sacks Director Company Registration No. 09917579
- 4 -
Cardiac Health Diagnostics Limited Notes to the Accounts for the year ended 31 December 2023
1
Statutory information
Cardiac Health Diagnostics Limited is a private company, limited by shares, registered in England and Wales, registration number 09917579. The registered office is White House Cottage, The Cathedral Green, Cardiff, South Glamorgan, CF5 2EB, Wales.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
These financial statements for the year ended 31 December 2023 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 January 2022. The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously. The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20&
Motor vehicles
25%
Fixtures & fittings
20%
Computer equipment
25%
Other tangible fixed assets
20%
- 5 -
Cardiac Health Diagnostics Limited Notes to the Accounts for the year ended 31 December 2023
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 January 2023
6,606 
At 31 December 2023
6,606 
Depreciation
At 1 January 2023
3,436 
Charge for the year
1,322 
At 31 December 2023
4,758 
Net book value
At 31 December 2023
1,848 
At 31 December 2022
3,170 
5
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Other creditors
2 
- 
Accruals
100 
- 
102 
- 
6
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Loans from directors
6,088 
6,088 
7
Average number of employees
During the year the average number of employees was 0 (2022: 0).
- 6 -